In 2021, the NGS sample preparation market size was $1,598.8 million, and with a compound annual growth rate of 14.7%, it is expected to reach $5,501.2 million in the next eight years. The technological advancements in NGS platforms and rising frequency of genetic ailments causing an increase in the demand for DTC genetic testing are the significant drivers. Moreover, the surge in the cases of infectious diseases is positively impacting the market. NGS sample preparation can be defined as the preparation of nucleic acid samples for investigation via next-generation sequencing.
NGS is widely utilized to diagnose genetic ailments; therefore, diagnostic laboratories’ genetic diagnosis consistency and accuracy are the major drivers for the NGS sample preparation market. Advanced genetic diagnostic techniques have enabled prenatal genetic testing. Due to the rising prevalence of genetic disorders, the efficiency of diagnostic screening is being increased. In order to enhance genome sequencing, reliable and high-throughput sample preparation is required, which can be achieved with automated sampling techniques.
The application segment of the NGS sample preparation market is dominated by DNA sequencing, which contributed 30% of the revenue in 2021. The significance of NGS sample preparation in DNA sequencing is high considering its cost-effectiveness and higher efficiency than manual sequencing. The present trend is expected to be followed in the coming years, especially with the COVID-19 pandemic not officially over yet. The NGS technology can be utilized to sequence the entire human or pathogen genome, which has allowed for the identification of COVID spread and mutation within individuals.
The largest revenue contributor in the NGS sample preparation market is North America. The favorable government and private initiatives for encouraging the usage of NGS for diagnosis and prognosis have allowed the regional market to prosper. Further, the region is a major hub for life sciences companies, which leads to the easy availability of products for NGS sampling. Moreover, APAC is expected to witness the fastest growth in the near future, attributed to the advancements in the medical research field and increase in the awareness of such solutions.
Therefore, the rising prevalence of genetic disorders and increasing demand for advanced medical research and genome sequencing are resulting in a boom in the market.